Research
-
VU researchers report G protein advancement that could lead to more effective drugs
Thanks in part to a computer program named “Rosetta,” Vanderbilt University researchers are closer to understanding how the ubiquitous G protein is activated – a discovery that could lead to the design of more specific and effective drugs. Read MoreDec 2, 2013
-
Autism narrows brain’s reward response
MRI brain scans reveal that children with autism spectrum disorders respond to a narrower range of familiar rewards. Read MoreNov 27, 2013
-
Mitochondrial mutations not random
A study of mitochondrial DNA mutations suggests they result from a process that selects for particular mutations in certain tissues. Read MoreNov 25, 2013
-
Vanderbilt celebrates 18 elected fellows of the AAAS
Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read MoreNov 25, 2013
-
Therapeutic target for synovial sarcoma
Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer. Read MoreNov 21, 2013
-
Study finds limited resources for injured surgeons
Nearly half of orthopaedic surgeons sustain at least one injury during their career and, in many cases, the resources available to them are inadequate, according to a Vanderbilt study in The Journal of Bone & Joint Surgery. Read MoreNov 21, 2013
-
Research contributions of VUMC nurses highlighted
Nursing research and evidence-based practice at Vanderbilt University Medical Center was on full display Nov. 13 at the annual Nursing Research Day. Read MoreNov 21, 2013
-
Patents should not have to be ‘useful’ to be approved: Vanderbilt professor
New inventions should not have to be useful to merit a patent, says Vanderbilt professor Sean B. Seymore. Read MoreNov 19, 2013
-
Heart Institute studying absorbable coronary stent
Vanderbilt Heart and Vascular Institute is participating in a clinical trial to evaluate a medical device for the treatment of coronary artery disease. Read MoreNov 14, 2013
-
Vanderbilt, Leipzig research collaboration sees strong results
During the past two weeks, the fifth international symposium between Leipzig and Vanderbilt universities was held on the Vanderbilt campus, as seven Leipzig faculty members presented a series of chemical biology-related lectures. Read MoreNov 14, 2013
-
Vision research group names VU graduate student to its board
Vanderbilt graduate student Megan Capozzi has been named the Member-In-Training Board of Trustee to the Association for Research in Vision and Ophthalmology (ARVO). Read MoreNov 14, 2013
-
Family’s support enhances cancer research training
John F. Brock III, chairman and CEO of Coca-Cola Enterprises, his wife, Mary, and their three children have established an endowment to support an oncology fellowship at Vanderbilt-Ingram Cancer Center. The Brock Family Fellowship will provide financial assistance long into the future for young physicians, postdoctoral students and medical investigators who are furthering their training in cancer research. Read MoreNov 14, 2013
-
Immunosuppressive drugs unlikely to raise fetal risk: study
Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism. Read MoreNov 14, 2013
-
Neon projects elite aura for amateur athletes
Bright-colored products and brands do more than just draw attention. They allow people to signal a personal identity that aligns them with elite athletes, explains Vanderbilt marketing professor Jennifer Escalas. Read MoreNov 13, 2013
-
Molecular circuits in ovarian cancer
Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer. Read MoreNov 13, 2013
-
Vanderbilt study: Hiring practices preventing change in law school faculties
Law school faculties are not changing with the times, and a Vanderbilt Law School professor says it may be time to look at hiring practices. Read MoreNov 12, 2013
-
Vanderbilt startup competes for $1M prize in Global Food and Health Innovation Challenge
Nashville startup InvisionHeart is a finalist for the Global Food and Health Innovation Challenge and will compete next week for a $1 million prize. InvisionHeart was created by a group at Vanderbilt University, including biomedical engineering professor Franz Baudenbacher and cardiac anesthesiologist Susan Eagle. Read MoreNov 11, 2013
-
Amish aid study of Parkinson genetics
Amish populations are valuable for genetic research because of their isolation, shared ancestry and homogeneous lifestyles. Read MoreNov 11, 2013
-
Defusing ‘C. diff’ infection
Clostridium difficile on the intestinal lining. (Wellcome Images) Clostridium difficile (“C. diff”) infection is a leading cause of hospital-associated diarrhea, and the frequency and severity of infections are on the rise. D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and colleagues recently demonstrated that the C. Read MoreNov 8, 2013
-
Neurotransmitter’s role in bone balance
Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling. Read MoreNov 7, 2013